The images above show more examples of abnormal nuclear segmentation in MDS; in simplistic terms the neutrophil nucleus should show a ‘string of sausages’ type orientation of nuclear segments. Though not 100% specific, we would encourage you to use this idea as a basis of defining normality. Note the variety of abnormal segmentation in each image above and the particularly odd orientation of nuclear lobes in the image extreme right.
Further examples are illustrated above; note the mature but non‐lobated nucleus in the neutrophil extreme left. Attention to the abnormal nuclear morphology might be lost when the eye is drawn to the cytoplasmic hypogranularity but the nuclear features shown here are significant.
Importantly, changes in neutrophil morphology can be reactive in nature so the clinical circumstances should be accounted for at the time of the blood film report, if the latter is to be fully informative. The images above are all from the peripheral blood of a patient with overwhelming bacterial sepsis; note the neutrophil hyposegmentation, including non‐lobated neutrophils and pseudo‐Pelger forms, together with cytoplasmic vacuolation and toxic granulation. Compare the above with the inherited condition Pelger–Huët anomaly (see Theme 38).
Neutrophil hypersegmentation can also be a feature of dysplasia but more frequently is seen in vitamin B12 or folic acid deficiency (above left). Reactive neutrophilia is common in inflammatory, infective and neoplastic conditions. The left centre image above is from a patient with a reactive neutrophilia as a response to corticosteroid therapy for small cell lung carcinoma. The image right centre shows a toxic type neutrophilia resulting from granulocyte colony‐stimulating factor (G‐CSF) therapy and the image extreme right is from a patient with septicaemia with neutrophils demonstrating Döhle bodies. Furthermore, and relevant to other cases in this text, neutrophil morphology can inform the diagnosis of inherited disease (see Theme 90).
The left image (above) shows prominent neutrophil cytoplasmic vacuolation due to lipid accumulation in a patient with neutral lipid storage disease, a finding known as Jordans anomaly. The right image is from a patient with recurrent serious bacterial infections due to neutrophil‐specific granule deficiency (previously known as lactoferrin deficiency). The automated analyser misinterpreted these cells as monocytes as they have very similar light scatter characteristics.
Other neutrophil abnormalities that can be found in MDS include binucleated macropolycytes (above images, extreme left and centre left, both with marked hypogranularity) and other tetraploid cells (segmented macropolycytes, above centre right and extreme right).
Other features of MDS include detached nuclear fragments, ring nuclei and nuclei with irregular projections (all images above) and with chromatin condensed into dense blocks (all images above) (Bain 2015). The spectrum of neutrophil morphological abnormalities that are informative in the diagnosis of MDS and AML are well summarised by the International Working Group on Morphology of MDS (IWGM‐MDS) (Goasguen et al. 2013).
References
1 Bain BJ (2015) Blood Cells, 5th Edn. Wiley‐Blackwell, Oxford, pp. 99–107.
2 Goasguen JE, Bennett JM, Bain BJ, Brunning R, Vallespie MT, Tomonaga M et al.; International Working Group on Morphology of MDS (IWGM‐MDS) (2013) Proposal for refining the definition of dysgranulopoiesis in acute myeloid leukemia and myelodysplastic syndromes. Leuk Res, 38, 447–453.
3 Karni RJ, Wangh LJ and Sanchez JA (2001) Nonrandom location and orientation of the inactive X chromosome in human neutrophil nuclei. Chromosoma, 110, 267–274.
MCQ
1 A botryoid (‘grape‐like’) nucleus in a neutrophil can be a feature of:BurnsGranulocyte colony‐stimulating factor (G‐CSF) therapyHyperthermiaMyelodysplastic syndromeSepsisFor answers and discussion, see page 206.
5 Primary myelofibrosis
A 40‐year‐old man underwent allogeneic stem cell transplantation for JAK2‐mutated primary myelofibrosis. His disease has recurred, and now 7 years later, he has been enrolled into a phase 1 clinical trial. He has massive splenomegaly which causes abdominal discomfort and early satiety but his blood counts are reasonably well preserved: Hb 126 g/l, WBC 5.3 × 109/l, neutrophils 4.1 × 109/l and platelets 348 × 109/l. A bone marrow trephine biopsy was taken as a baseline at enrolment and the sections are illustrated above. On H&E staining the marrow showed marked hypercellularity, approaching 100%, largely due to a marked increase in large pleomorphic megakaryocytes (top images ×50 objective). These showed inevitable gross clustering. There was a marked increase in stainable reticulin to grade 3/3 with the reticulin fibres often laid down circumferentially around the megakaryocytes (bottom left). There was a marked increase in marrow sinusoids (note the CD34 expression by the endothelial cells) and the megakaryocytes showed aberrant CD34 expression (CD34, bottom centre, immunoperoxidase). The variation in megakaryocyte size is also illustrated here with giant forms being common, though much smaller forms are also evident (CD42b, bottom right, immunoperoxidase).
Primary myelofibrosis is a myeloproliferative neoplasm characterised by megakaryocyte proliferation, associated progressive bone marrow fibrosis/osteosclerosis and a propensity to evolve to acute myeloid leukaemia. Due to compromise of the bone marrow compartment, extramedullary haemopoiesis follows with involvement of the liver and particularly the spleen. Progressive bone marrow fibrosis causes bone marrow failure which is further compounded by hypersplenism. Patients develop abdominal pain and early satiety due to splenomegaly together with night sweats, fatigue and weight loss from the catabolic effect of the disease. Treatments such as ruxolitinib, a JAK‐STAT pathway inhibitor, are useful for splenic symptoms and sweats. Ruxolitinib prolongs survival in myelofibrosis but the only potential curative treatment is allogeneic bone marrow transplantation. There is an unmet need for effective treatment of myelofibrosis.
The blood film